These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

157 related articles for article (PubMed ID: 27001978)

  • 1. Compounding oversight a work in progress for states, FDA.
    Traynor K
    Am J Health Syst Pharm; 2016 Apr; 73(7):424-5. PubMed ID: 27001978
    [No Abstract]   [Full Text] [Related]  

  • 2. Regulation of compounding by the food and drug administration: a tale of 2 circuits.
    Williams KG
    J Pharm Pract; 2010 Oct; 23(5):502-6. PubMed ID: 21507854
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Regulators faulted for inadequate compounding pharmacy oversight.
    Traynor K
    Am J Health Syst Pharm; 2013 Jan; 70(1):8-10. PubMed ID: 23261891
    [No Abstract]   [Full Text] [Related]  

  • 4. Compounding pharmacy industry has outgrown its regulatory system, ASHP and FDA say.
    Thompson CA
    Am J Health Syst Pharm; 2013 May; 70(9):747-8. PubMed ID: 23592352
    [No Abstract]   [Full Text] [Related]  

  • 5. Potential risks of pharmacy compounding.
    Gudeman J; Jozwiakowski M; Chollet J; Randell M
    Drugs R D; 2013 Mar; 13(1):1-8. PubMed ID: 23526368
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Discrepancies in the Law and the U.S. Food and Drug Administration Pharmacy Compounding Compliance Policy Guidelines.
    Allen LV
    Int J Pharm Compd; 2016; 20(4):351. PubMed ID: 28333682
    [No Abstract]   [Full Text] [Related]  

  • 7. Discretion of the Food and Drug Administration to enforce compounding rules.
    Liu W; Knox CA; Brushwood DB
    Am J Health Syst Pharm; 2013 Sep; 70(17):1538-43. PubMed ID: 23943187
    [No Abstract]   [Full Text] [Related]  

  • 8. Compounding pharmacy oversight moves ahead.
    Traynor K
    Am J Health Syst Pharm; 2013 Jun; 70(11):920, 922, 924. PubMed ID: 23686593
    [No Abstract]   [Full Text] [Related]  

  • 9. FDA Expands List of "Do Not Compound" Drug Products.
    Food and Drug Administration, Public Health Service, U.S. Department of Health and Human Services
    J Pain Palliat Care Pharmacother; 2017 Mar; 31(1):76-78. PubMed ID: 28287350
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Compliance policy guide addresses prescription drug compounding.
    Ann Pharmacother; 1992 Jun; 26(6):868. PubMed ID: 1611176
    [No Abstract]   [Full Text] [Related]  

  • 11. NABP to inspect compounding pharmacies.
    Traynor K
    Am J Health Syst Pharm; 2013 Jan; 70(2):88-90. PubMed ID: 23292258
    [No Abstract]   [Full Text] [Related]  

  • 12. International Academy of Compounding Pharmacists' Legislative Regulatory Update: Take Action! Stop the U.S. Food and Drug Administration's Misguided Veterinary Guidance.
    Miller DG
    Int J Pharm Compd; 2015; 19(6):449-50. PubMed ID: 26891558
    [No Abstract]   [Full Text] [Related]  

  • 13. Application of standards for compounding.
    Newton DW
    J Am Vet Med Assoc; 1994 Jul; 205(2):232-4. PubMed ID: 7928584
    [No Abstract]   [Full Text] [Related]  

  • 14. FDA moves to curb drug counterfeiting.
    Ault A
    Lancet; 2003 Jul; 362(9380):301. PubMed ID: 12894797
    [No Abstract]   [Full Text] [Related]  

  • 15. IACP's continuing support of compounding pharmacists: letter to the FDA concerning 503B outsourcing facilities.
    Miller DG
    Int J Pharm Compd; 2014; 18(2):117-8. PubMed ID: 24881114
    [No Abstract]   [Full Text] [Related]  

  • 16. FDA culls nominations for compounding list.
    Landis NT
    Am J Health Syst Pharm; 1999 Jul; 56(14):1388, 1391. PubMed ID: 10428443
    [No Abstract]   [Full Text] [Related]  

  • 17. U.S. Food and Drug Administration requests for input on HR 3204 enactment: the Drug Quality and Security Act of 2013.
    Miller DG
    Int J Pharm Compd; 2014; 18(1):35-6. PubMed ID: 24881338
    [No Abstract]   [Full Text] [Related]  

  • 18. Senate mulls oversight of pharmacy compounding.
    Young D
    Am J Health Syst Pharm; 2003 Dec; 60(23):2402, 2404, 2406. PubMed ID: 14686214
    [No Abstract]   [Full Text] [Related]  

  • 19. Compounding can be confounding.
    Waldo MN
    Insight; 2013; 38(2):3. PubMed ID: 23724552
    [No Abstract]   [Full Text] [Related]  

  • 20. The U.S. Food and Drug Administration responds to the International Academy of Compounding Pharmacists' outsourcing letter.
    Int J Pharm Compd; 2014; 18(3):208. PubMed ID: 25306767
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.